Ignite Creation Date:
2025-12-25 @ 12:30 AM
Ignite Modification Date:
2025-12-25 @ 10:37 PM
Study NCT ID:
NCT01218867
Status:
TERMINATED
Last Update Posted:
2019-12-10
First Post:
2010-10-08
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
CAR T Cell Receptor Immunotherapy Targeting VEGFR2 for Patients With Metastatic Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-11-10
Start Date Type:
ACTUAL
Primary Completion Date:
2014-09-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-12-15
Completion Date Type:
ACTUAL
First Submit Date:
2010-10-08
First Submit QC Date:
None
Study First Post Date:
2010-10-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-04-15
Results First Submit QC Date:
None
Results First Post Date:
2016-07-22
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-11-18
Last Update Post Date:
2019-12-10
Last Update Post Date Type:
ACTUAL